New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 6, 2013
18:36 EDTALNYAlnylam aims to advance ALN-TTR02 into Phase III pivotal trial
Alnylam aims to advance ALN-TTR02 into Phase III pivotal trial in Transthyretin, TTR -mediated amyloidosis, ATTR, Patients with Familial Amyloidotic Polyneuropathy, FAP, by late 2013; Phase II data expected in mid-2013.
News For ALNY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 28, 2014
08:10 EDTALNYAlnylam, The Medicines Co. file application to initiate Phase 1 ALN-PCSsc study
Subscribe for More Information
October 27, 2014
07:04 EDTALNYAlnylam management to meet with Deutsche Bank
Subscribe for More Information
October 21, 2014
09:48 EDTALNYShire could target BioMarin, TheStreet's Feuerstein says
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use